Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia
- Autores
- Olea, Fernanda Daniela; Vera Janavel, G.; Cuniberti, Luis Alberto; Yannarelli, Gustavo Gabriel; Cabeza Meckert, Patricia; Cors, J.; Valdivieso, L.; Lev, G.; Mendiz, O.; Bercovich, A.; Criscuolo, M.; Melo, C.; Laguens, R.; Crottogini, Alberto José
- Año de publicación
- 2009
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Vascular endothelial growth factor (VEGF) gene transfer-mediated angiogenesis has been proposed for peripheral artery disease. However, protocols using single administration have shown little benefit. Given that the transient nature of VEGF gene expression provokes instability of neovasculature, we hypothesized that repeated administration would provide efficient tissue protection. We thus compared single vs repeated transfection in a rabbit model of hindlimb ischemia by injecting a plasmid encoding human VEGF165 (pVEGF165) at 7 (GI, n=10) or 7 and 21 (GII, n=10) days after surgery. Placebo animals (GIII, n=10) received empty plasmid. Fifty days after surgery, single and repeated administration similarly increased saphenous peak flow velocity and quantity of angiographically visible collaterals. However, microvasculature increased only with repeated transfection: capillary density was 49.4±15.4 capillaries per 100 myocytes in GI, 84.6±14.7 in GII (P<0.01 vs GI and GIII) and 49.3±13.6 in GIII, and arteriolar density was 1.9±0.6 arterioles per mm2 in GI, 3.0±0.9 in GII (P<0.01 vs GI and GIII) and 1.5±0.6 in GIII. Muscle lesions were reduced only within repeated transfection. With single administration, gene expression peaked at 7 days and declined rapidly, but with repeated administration, it remained positive at 50 days. At 90 days of repeated transfection (additional animals), gene expression decreased significantly, but neovessel densities did not. Thus, repeated, but not single, VEGF gene transfection resulted in increased microvasculature, which, in turn, afforded effective protection against ischemic muscle damage.
Fil: Olea, Fernanda Daniela. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Vera Janavel, G.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina
Fil: Cuniberti, Luis Alberto. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Yannarelli, Gustavo Gabriel. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina
Fil: Cabeza Meckert, Patricia. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Provincia de Buenos Aires. Gobernación. Comisión de Investigaciones Científicas; Argentina
Fil: Cors, J.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina
Fil: Valdivieso, L.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina
Fil: Lev, G.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina
Fil: Mendiz, O.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina
Fil: Bercovich, A.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina
Fil: Criscuolo, M.. Biosidus S. A.; Argentina
Fil: Melo, C.. Biosidus S. A.; Argentina
Fil: Laguens, R.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina
Fil: Crottogini, Alberto José. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina - Materia
-
VEGF
PERIPHERAL ARTERY DISEASE
ANGIOGENESIS
HINDLIMB ISCHEMIA - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/96244
Ver los metadatos del registro completo
id |
CONICETDig_f7f251284bd974ab496f7d71e965a9ac |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/96244 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemiaOlea, Fernanda DanielaVera Janavel, G.Cuniberti, Luis AlbertoYannarelli, Gustavo GabrielCabeza Meckert, PatriciaCors, J.Valdivieso, L.Lev, G.Mendiz, O.Bercovich, A.Criscuolo, M.Melo, C.Laguens, R.Crottogini, Alberto JoséVEGFPERIPHERAL ARTERY DISEASEANGIOGENESISHINDLIMB ISCHEMIAhttps://purl.org/becyt/ford/3.5https://purl.org/becyt/ford/3Vascular endothelial growth factor (VEGF) gene transfer-mediated angiogenesis has been proposed for peripheral artery disease. However, protocols using single administration have shown little benefit. Given that the transient nature of VEGF gene expression provokes instability of neovasculature, we hypothesized that repeated administration would provide efficient tissue protection. We thus compared single vs repeated transfection in a rabbit model of hindlimb ischemia by injecting a plasmid encoding human VEGF165 (pVEGF165) at 7 (GI, n=10) or 7 and 21 (GII, n=10) days after surgery. Placebo animals (GIII, n=10) received empty plasmid. Fifty days after surgery, single and repeated administration similarly increased saphenous peak flow velocity and quantity of angiographically visible collaterals. However, microvasculature increased only with repeated transfection: capillary density was 49.4±15.4 capillaries per 100 myocytes in GI, 84.6±14.7 in GII (P<0.01 vs GI and GIII) and 49.3±13.6 in GIII, and arteriolar density was 1.9±0.6 arterioles per mm2 in GI, 3.0±0.9 in GII (P<0.01 vs GI and GIII) and 1.5±0.6 in GIII. Muscle lesions were reduced only within repeated transfection. With single administration, gene expression peaked at 7 days and declined rapidly, but with repeated administration, it remained positive at 50 days. At 90 days of repeated transfection (additional animals), gene expression decreased significantly, but neovessel densities did not. Thus, repeated, but not single, VEGF gene transfection resulted in increased microvasculature, which, in turn, afforded effective protection against ischemic muscle damage.Fil: Olea, Fernanda Daniela. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Vera Janavel, G.. Universidad Favaloro. Área de Investigación y Desarrollo; ArgentinaFil: Cuniberti, Luis Alberto. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Yannarelli, Gustavo Gabriel. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaFil: Cabeza Meckert, Patricia. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Provincia de Buenos Aires. Gobernación. Comisión de Investigaciones Científicas; ArgentinaFil: Cors, J.. Universidad Favaloro. Área de Investigación y Desarrollo; ArgentinaFil: Valdivieso, L.. Universidad Favaloro. Área de Investigación y Desarrollo; ArgentinaFil: Lev, G.. Universidad Favaloro. Área de Investigación y Desarrollo; ArgentinaFil: Mendiz, O.. Universidad Favaloro. Área de Investigación y Desarrollo; ArgentinaFil: Bercovich, A.. Universidad Favaloro. Área de Investigación y Desarrollo; ArgentinaFil: Criscuolo, M.. Biosidus S. A.; ArgentinaFil: Melo, C.. Biosidus S. A.; ArgentinaFil: Laguens, R.. Universidad Favaloro. Área de Investigación y Desarrollo; ArgentinaFil: Crottogini, Alberto José. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; ArgentinaNature Publishing Group2009-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/96244Olea, Fernanda Daniela; Vera Janavel, G.; Cuniberti, Luis Alberto; Yannarelli, Gustavo Gabriel; Cabeza Meckert, Patricia; et al.; Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia; Nature Publishing Group; Gene Therapy; 16; 6; 6-2009; 716-7230969-7128CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/gt200930info:eu-repo/semantics/altIdentifier/doi/10.1038/gt.2009.30info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T14:40:51Zoai:ri.conicet.gov.ar:11336/96244instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 14:40:51.51CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia |
title |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia |
spellingShingle |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia Olea, Fernanda Daniela VEGF PERIPHERAL ARTERY DISEASE ANGIOGENESIS HINDLIMB ISCHEMIA |
title_short |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia |
title_full |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia |
title_fullStr |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia |
title_full_unstemmed |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia |
title_sort |
Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia |
dc.creator.none.fl_str_mv |
Olea, Fernanda Daniela Vera Janavel, G. Cuniberti, Luis Alberto Yannarelli, Gustavo Gabriel Cabeza Meckert, Patricia Cors, J. Valdivieso, L. Lev, G. Mendiz, O. Bercovich, A. Criscuolo, M. Melo, C. Laguens, R. Crottogini, Alberto José |
author |
Olea, Fernanda Daniela |
author_facet |
Olea, Fernanda Daniela Vera Janavel, G. Cuniberti, Luis Alberto Yannarelli, Gustavo Gabriel Cabeza Meckert, Patricia Cors, J. Valdivieso, L. Lev, G. Mendiz, O. Bercovich, A. Criscuolo, M. Melo, C. Laguens, R. Crottogini, Alberto José |
author_role |
author |
author2 |
Vera Janavel, G. Cuniberti, Luis Alberto Yannarelli, Gustavo Gabriel Cabeza Meckert, Patricia Cors, J. Valdivieso, L. Lev, G. Mendiz, O. Bercovich, A. Criscuolo, M. Melo, C. Laguens, R. Crottogini, Alberto José |
author2_role |
author author author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
VEGF PERIPHERAL ARTERY DISEASE ANGIOGENESIS HINDLIMB ISCHEMIA |
topic |
VEGF PERIPHERAL ARTERY DISEASE ANGIOGENESIS HINDLIMB ISCHEMIA |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.5 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Vascular endothelial growth factor (VEGF) gene transfer-mediated angiogenesis has been proposed for peripheral artery disease. However, protocols using single administration have shown little benefit. Given that the transient nature of VEGF gene expression provokes instability of neovasculature, we hypothesized that repeated administration would provide efficient tissue protection. We thus compared single vs repeated transfection in a rabbit model of hindlimb ischemia by injecting a plasmid encoding human VEGF165 (pVEGF165) at 7 (GI, n=10) or 7 and 21 (GII, n=10) days after surgery. Placebo animals (GIII, n=10) received empty plasmid. Fifty days after surgery, single and repeated administration similarly increased saphenous peak flow velocity and quantity of angiographically visible collaterals. However, microvasculature increased only with repeated transfection: capillary density was 49.4±15.4 capillaries per 100 myocytes in GI, 84.6±14.7 in GII (P<0.01 vs GI and GIII) and 49.3±13.6 in GIII, and arteriolar density was 1.9±0.6 arterioles per mm2 in GI, 3.0±0.9 in GII (P<0.01 vs GI and GIII) and 1.5±0.6 in GIII. Muscle lesions were reduced only within repeated transfection. With single administration, gene expression peaked at 7 days and declined rapidly, but with repeated administration, it remained positive at 50 days. At 90 days of repeated transfection (additional animals), gene expression decreased significantly, but neovessel densities did not. Thus, repeated, but not single, VEGF gene transfection resulted in increased microvasculature, which, in turn, afforded effective protection against ischemic muscle damage. Fil: Olea, Fernanda Daniela. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Vera Janavel, G.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina Fil: Cuniberti, Luis Alberto. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Yannarelli, Gustavo Gabriel. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina Fil: Cabeza Meckert, Patricia. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Provincia de Buenos Aires. Gobernación. Comisión de Investigaciones Científicas; Argentina Fil: Cors, J.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina Fil: Valdivieso, L.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina Fil: Lev, G.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina Fil: Mendiz, O.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina Fil: Bercovich, A.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina Fil: Criscuolo, M.. Biosidus S. A.; Argentina Fil: Melo, C.. Biosidus S. A.; Argentina Fil: Laguens, R.. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina Fil: Crottogini, Alberto José. Universidad Favaloro. Área de Investigación y Desarrollo; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina |
description |
Vascular endothelial growth factor (VEGF) gene transfer-mediated angiogenesis has been proposed for peripheral artery disease. However, protocols using single administration have shown little benefit. Given that the transient nature of VEGF gene expression provokes instability of neovasculature, we hypothesized that repeated administration would provide efficient tissue protection. We thus compared single vs repeated transfection in a rabbit model of hindlimb ischemia by injecting a plasmid encoding human VEGF165 (pVEGF165) at 7 (GI, n=10) or 7 and 21 (GII, n=10) days after surgery. Placebo animals (GIII, n=10) received empty plasmid. Fifty days after surgery, single and repeated administration similarly increased saphenous peak flow velocity and quantity of angiographically visible collaterals. However, microvasculature increased only with repeated transfection: capillary density was 49.4±15.4 capillaries per 100 myocytes in GI, 84.6±14.7 in GII (P<0.01 vs GI and GIII) and 49.3±13.6 in GIII, and arteriolar density was 1.9±0.6 arterioles per mm2 in GI, 3.0±0.9 in GII (P<0.01 vs GI and GIII) and 1.5±0.6 in GIII. Muscle lesions were reduced only within repeated transfection. With single administration, gene expression peaked at 7 days and declined rapidly, but with repeated administration, it remained positive at 50 days. At 90 days of repeated transfection (additional animals), gene expression decreased significantly, but neovessel densities did not. Thus, repeated, but not single, VEGF gene transfection resulted in increased microvasculature, which, in turn, afforded effective protection against ischemic muscle damage. |
publishDate |
2009 |
dc.date.none.fl_str_mv |
2009-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/96244 Olea, Fernanda Daniela; Vera Janavel, G.; Cuniberti, Luis Alberto; Yannarelli, Gustavo Gabriel; Cabeza Meckert, Patricia; et al.; Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia; Nature Publishing Group; Gene Therapy; 16; 6; 6-2009; 716-723 0969-7128 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/96244 |
identifier_str_mv |
Olea, Fernanda Daniela; Vera Janavel, G.; Cuniberti, Luis Alberto; Yannarelli, Gustavo Gabriel; Cabeza Meckert, Patricia; et al.; Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia; Nature Publishing Group; Gene Therapy; 16; 6; 6-2009; 716-723 0969-7128 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://www.nature.com/articles/gt200930 info:eu-repo/semantics/altIdentifier/doi/10.1038/gt.2009.30 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Nature Publishing Group |
publisher.none.fl_str_mv |
Nature Publishing Group |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1846082902141435904 |
score |
13.22299 |